T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model

Emma H. A. Stahlie, Viola Franke, Charlotte L. Zuur, W. Martin C. Klop, Bernies van der Hiel, Bart A. van de Wiel, Michel W.J.M. Wouters, Yvonne Schrage, Winan J. van Houdt, Alexander C. J. van Akkooi